These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1986214)

  • 1. Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells.
    Johnson P; Gray D; Mowat M; Benchimol S
    Mol Cell Biol; 1991 Jan; 11(1):1-11. PubMed ID: 1986214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
    Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
    Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
    Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
    New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles.
    Munroe DG; Peacock JW; Benchimol S
    Mol Cell Biol; 1990 Jul; 10(7):3307-13. PubMed ID: 1694008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 is frequently mutated in Burkitt's lymphoma cell lines.
    Farrell PJ; Allan GJ; Shanahan F; Vousden KH; Crook T
    EMBO J; 1991 Oct; 10(10):2879-87. PubMed ID: 1915267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
    Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
    Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the p53 gene in human uterine carcinoma cell lines.
    Yaginuma Y; Westphal H
    Cancer Res; 1991 Dec; 51(24):6506-9. PubMed ID: 1660340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic basis for p53 overexpression in human breast cancer.
    Davidoff AM; Humphrey PA; Iglehart JD; Marks JR
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5006-10. PubMed ID: 2052583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
    Rauth S; Green A; Kichina J; Shilkaitis A
    Br J Cancer; 1998 Jun; 77(12):2215-22. PubMed ID: 9649136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
    Shaulsky G; Goldfinger N; Rotter V
    Cancer Res; 1991 Oct; 51(19):5232-7. PubMed ID: 1717142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.
    Trepel M; Groscurth P; Malipiero U; Gulbins E; Dichgans J; Weller M
    J Neurooncol; 1998 Aug; 39(1):19-32. PubMed ID: 9760067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the p53 gene and its expression in human glioblastoma cells.
    Van Meir EG; Kikuchi T; Tada M; Li H; Diserens AC; Wojcik BE; Huang HJ; Friedmann T; de Tribolet N; Cavenee WK
    Cancer Res; 1994 Feb; 54(3):649-52. PubMed ID: 8306326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
    Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
    Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
    Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
    Asai A; Miyagi Y; Sugiyama A; Gamanuma M; Hong SH; Takamoto S; Nomura K; Matsutani M; Takakura K; Kuchino Y
    J Neurooncol; 1994; 19(3):259-68. PubMed ID: 7807177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
    Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
    Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of wild-type p53 in pre-B-cell differentiation in vitro.
    Shaulsky G; Goldfinger N; Peled A; Rotter V
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8982-6. PubMed ID: 1924360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
    Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
    Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.